Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
All cancer types
Closed
Phase 1
This trial is looking at a new drug called BYL719 for advanced solid tumours. It is for people whose cancer cells have a change to a gene called PIK3CA.
Recruitment start: 5 October 2010
Recruitment end: 4 March 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mark Middleton
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 10 Apr 2014
CRUK internal database number: 7816
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
